Abciximab therapy improves 1-month survival rate in unselected patients with acute myocardial infarction undergoing routine infarct artery stent implantation.
- czytaj na:
kardiolog.pl
Leczenie przeciwpłytkowe w ostrym zawale serca z uniesieniem odcinka ST - najnowsze wytyczne
- czytaj na:
kardiolog.pl
Abciximab rekomendowany do inwazyjnego leczenia STEMI przez PTK
- czytaj na:
kardiolog.pl
Abciximab therapy improves survival in patients with acute myocardial infarction complicated by early cardiogenic shock undergoing coronary artery stent implantation.
- czytaj na:
kardiolog.pl
Comparison of ReoPro® (abciximab) versus intracoronary thrombolysis for early coronary stent thrombosis
- czytaj na:
kardiolog.pl
Decrease of vascular smooth muscle cell locomotion by abciximab, but not tirofiban: a possible role of different affinity to alpha v beta 3 integrins
- czytaj na:
kardiolog.pl
Differential benefits and outcomes of tirofiban vs abciximab for acute coronary syndromes in current clinical practice
- czytaj na:
kardiolog.pl
Differential benefits and outcomes of tirofiban vs abciximab for acute coronary syndromes in current clinical practice
- czytaj na:
kardiolog.pl
Early administration of reteplase plus abciximab vs abciximab alone in patients with acute myocardial infarction referred for percutaneous coronary intervention: a randomized controlled trial.
- czytaj na:
kardiolog.pl
Effect of fibrinogen concentration and platelet count on the inhibitory effect of abciximab and tirofiban
- czytaj na:
kardiolog.pl
Effectiveness of the glycoprotein IIb/IIIa antagonist abciximab during percutaneous coronary interventions (PCI) in clinical practice at a single high-volume center.
- czytaj na:
kardiolog.pl
Effects of abciximab on microvascular integrity and left ventricular functional recovery in patients with acute infarction treated by primary coronary angioplasty
- czytaj na:
kardiolog.pl